Advertisement - Members don't see this ad
Just your thoughts on evaluating a drug that completed phase 1, 2 and 3 in two different situations. What do you guys think?
1) You are a member of a consulting group hired by BigPharma to provide comments and suggestions about the new drug. What do you want to know?
2) You are a member of a consulting group hired by the FDA to provide comments and suggestions about the new drug. What do you want to know?
Obviously there will be a conflict of interest, but was wondering what you guys thought about this. What would be the difference?
1) You are a member of a consulting group hired by BigPharma to provide comments and suggestions about the new drug. What do you want to know?
2) You are a member of a consulting group hired by the FDA to provide comments and suggestions about the new drug. What do you want to know?
Obviously there will be a conflict of interest, but was wondering what you guys thought about this. What would be the difference?
